The diagnostic value of 124I-PET in patients with differentiated thyroid cancer
Background The purpose of this prospective study was to evaluate the clinical diagnostic value of iodine-124 ( 124 I)-positron emission tomography (PET) in patients with advanced differentiated thyroid carcinoma (DTC) and to compare the 124 I-PET imaging results with the 131 I whole-body scan (WBS)....
Gespeichert in:
| Veröffentlicht in: | European journal of nuclear medicine and molecular imaging 2008-05, Vol.35 (5), p.958-965 |
|---|---|
| Hauptverfasser: | , , , , , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 965 |
|---|---|
| container_issue | 5 |
| container_start_page | 958 |
| container_title | European journal of nuclear medicine and molecular imaging |
| container_volume | 35 |
| creator | Phan, Ha T. T. Jager, Pieter L. Paans, Anne M. J. Plukker, John T. M. Sturkenboom, M. G. G. Sluiter, W. J. Wolffenbuttel, Bruce H. R. Dierckx, Rudi A. J. O. Links, Thera P. |
| description | Background
The purpose of this prospective study was to evaluate the clinical diagnostic value of iodine-124 (
124
I)-positron emission tomography (PET) in patients with advanced differentiated thyroid carcinoma (DTC) and to compare the
124
I-PET imaging results with the
131
I whole-body scan (WBS).
Materials and methods
Twenty patients with histologically proven advanced DTC (including T4, extra-nodal tumour growth, or distant metastases) underwent diagnostic
131
I-WBS,
124
I-PET scan, and post-treatment
131
I-WBS 4 months after ablation. The findings on the
124
I-PET were compared with the findings on the diagnostic and post-therapeutic
131
I-WBS and were also correlated with radiologic and/or cytological investigations.
Results
124
I-PET vs diagnostic
131
I-WBS
. Eleven patients showed uptake on the
124
I-PET. Only 3 of these 11 patients also showed uptake on the diagnostic
131
I scan, but the uptake was more clearly visible and the abnormalities were more extensive on the
124
I-PET.
124
I-PET vs post-treatment
131
I-WBS
. Eleven patients showed uptake on the
124
I-PET, which was also visible on the post-treatment scan in nine patients; in the other two patients, no uptake was observed on the post-treatment scan and no anatomical localisation could be confirmed. Two patients showed only uptake on the post-treatment scan without uptake on the
124
I-PET: in one, the uptake was confirmed by MRI, and in the other, no anatomical localisation was found. In seven patients, no uptake was observed on both the scans.
Conclusion
124
I-PET proved to be a superior diagnostic tool as compared to low-dose diagnostic
131
I scans and adequately predicted findings on subsequent high-dose post-treatment
131
I scans. |
| doi_str_mv | 10.1007/s00259-007-0660-6 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_2292795</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>1468404171</sourcerecordid><originalsourceid>FETCH-LOGICAL-c3126-a473650ae081c827ee621d8a3401784adc25932b4ec958f74e6a26927b6cee423</originalsourceid><addsrcrecordid>eNp1kU9rGzEQxUVpadK0H6CXInrobduRVn8vhRKSNBBIDs5ZyNpZW2G9cqXdhHz7ytgkbSAnPTG_eTPDI-Qzg-8MQP8oAFzapsoGlIJGvSHHTDHbaDD27ZPWcEQ-lHIHwAw39j05YoZpyZg8JteLNdIu-tWYyhQDvffDjDT1lHFx2dycLWgc6dZPEcep0Ic4rSvd95jrP_oJOzqtH3OKHQ1-DJg_kne9Hwp-Orwn5Pb8bHH6u7m6vrg8_XXVhJZx1XihWyXBIxgWDNeIirPO-FYA00b4LtTDWr4UGKw0vRaoPFeW66UKiIK3J-Tn3nc7LzfYhbpO9oPb5rjx-dElH93_lTGu3SrdO86ri5XV4NvBIKc_M5bJbWIJOAx-xDQXp0GCVFJX8OsL8C7NeazHOc6EEspaUSG2h0JOpWTsnzZh4HZZuX1Wbid3WTlVe778e8JzxyGcCvA9UGppXGF-nvy6619v4J4d</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>214646994</pqid></control><display><type>article</type><title>The diagnostic value of 124I-PET in patients with differentiated thyroid cancer</title><source>MEDLINE</source><source>SpringerLink Journals - AutoHoldings</source><creator>Phan, Ha T. T. ; Jager, Pieter L. ; Paans, Anne M. J. ; Plukker, John T. M. ; Sturkenboom, M. G. G. ; Sluiter, W. J. ; Wolffenbuttel, Bruce H. R. ; Dierckx, Rudi A. J. O. ; Links, Thera P.</creator><creatorcontrib>Phan, Ha T. T. ; Jager, Pieter L. ; Paans, Anne M. J. ; Plukker, John T. M. ; Sturkenboom, M. G. G. ; Sluiter, W. J. ; Wolffenbuttel, Bruce H. R. ; Dierckx, Rudi A. J. O. ; Links, Thera P.</creatorcontrib><description>Background
The purpose of this prospective study was to evaluate the clinical diagnostic value of iodine-124 (
124
I)-positron emission tomography (PET) in patients with advanced differentiated thyroid carcinoma (DTC) and to compare the
124
I-PET imaging results with the
131
I whole-body scan (WBS).
Materials and methods
Twenty patients with histologically proven advanced DTC (including T4, extra-nodal tumour growth, or distant metastases) underwent diagnostic
131
I-WBS,
124
I-PET scan, and post-treatment
131
I-WBS 4 months after ablation. The findings on the
124
I-PET were compared with the findings on the diagnostic and post-therapeutic
131
I-WBS and were also correlated with radiologic and/or cytological investigations.
Results
124
I-PET vs diagnostic
131
I-WBS
. Eleven patients showed uptake on the
124
I-PET. Only 3 of these 11 patients also showed uptake on the diagnostic
131
I scan, but the uptake was more clearly visible and the abnormalities were more extensive on the
124
I-PET.
124
I-PET vs post-treatment
131
I-WBS
. Eleven patients showed uptake on the
124
I-PET, which was also visible on the post-treatment scan in nine patients; in the other two patients, no uptake was observed on the post-treatment scan and no anatomical localisation could be confirmed. Two patients showed only uptake on the post-treatment scan without uptake on the
124
I-PET: in one, the uptake was confirmed by MRI, and in the other, no anatomical localisation was found. In seven patients, no uptake was observed on both the scans.
Conclusion
124
I-PET proved to be a superior diagnostic tool as compared to low-dose diagnostic
131
I scans and adequately predicted findings on subsequent high-dose post-treatment
131
I scans.</description><identifier>ISSN: 1619-7070</identifier><identifier>EISSN: 1619-7089</identifier><identifier>DOI: 10.1007/s00259-007-0660-6</identifier><identifier>PMID: 18175115</identifier><language>eng</language><publisher>Berlin/Heidelberg: Springer Berlin Heidelberg</publisher><subject>Adult ; Aged ; Aged, 80 and over ; Cardiology ; Comparative studies ; Female ; Humans ; Imaging ; Iodine Radioisotopes ; Male ; Medicine ; Medicine & Public Health ; Middle Aged ; Nuclear Medicine ; Oncology ; Original ; Original Article ; Orthopedics ; Positron-Emission Tomography - methods ; Radiology ; Radiopharmaceuticals ; Reproducibility of Results ; Sensitivity and Specificity ; Thyroid cancer ; Thyroid diseases ; Thyroid Neoplasms - diagnostic imaging ; Tomography</subject><ispartof>European journal of nuclear medicine and molecular imaging, 2008-05, Vol.35 (5), p.958-965</ispartof><rights>The Author(s) 2007</rights><rights>Springer-Verlag 2008</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c3126-a473650ae081c827ee621d8a3401784adc25932b4ec958f74e6a26927b6cee423</citedby><cites>FETCH-LOGICAL-c3126-a473650ae081c827ee621d8a3401784adc25932b4ec958f74e6a26927b6cee423</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://link.springer.com/content/pdf/10.1007/s00259-007-0660-6$$EPDF$$P50$$Gspringer$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://link.springer.com/10.1007/s00259-007-0660-6$$EHTML$$P50$$Gspringer$$Hfree_for_read</linktohtml><link.rule.ids>230,314,780,784,885,27924,27925,41488,42557,51319</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/18175115$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Phan, Ha T. T.</creatorcontrib><creatorcontrib>Jager, Pieter L.</creatorcontrib><creatorcontrib>Paans, Anne M. J.</creatorcontrib><creatorcontrib>Plukker, John T. M.</creatorcontrib><creatorcontrib>Sturkenboom, M. G. G.</creatorcontrib><creatorcontrib>Sluiter, W. J.</creatorcontrib><creatorcontrib>Wolffenbuttel, Bruce H. R.</creatorcontrib><creatorcontrib>Dierckx, Rudi A. J. O.</creatorcontrib><creatorcontrib>Links, Thera P.</creatorcontrib><title>The diagnostic value of 124I-PET in patients with differentiated thyroid cancer</title><title>European journal of nuclear medicine and molecular imaging</title><addtitle>Eur J Nucl Med Mol Imaging</addtitle><addtitle>Eur J Nucl Med Mol Imaging</addtitle><description>Background
The purpose of this prospective study was to evaluate the clinical diagnostic value of iodine-124 (
124
I)-positron emission tomography (PET) in patients with advanced differentiated thyroid carcinoma (DTC) and to compare the
124
I-PET imaging results with the
131
I whole-body scan (WBS).
Materials and methods
Twenty patients with histologically proven advanced DTC (including T4, extra-nodal tumour growth, or distant metastases) underwent diagnostic
131
I-WBS,
124
I-PET scan, and post-treatment
131
I-WBS 4 months after ablation. The findings on the
124
I-PET were compared with the findings on the diagnostic and post-therapeutic
131
I-WBS and were also correlated with radiologic and/or cytological investigations.
Results
124
I-PET vs diagnostic
131
I-WBS
. Eleven patients showed uptake on the
124
I-PET. Only 3 of these 11 patients also showed uptake on the diagnostic
131
I scan, but the uptake was more clearly visible and the abnormalities were more extensive on the
124
I-PET.
124
I-PET vs post-treatment
131
I-WBS
. Eleven patients showed uptake on the
124
I-PET, which was also visible on the post-treatment scan in nine patients; in the other two patients, no uptake was observed on the post-treatment scan and no anatomical localisation could be confirmed. Two patients showed only uptake on the post-treatment scan without uptake on the
124
I-PET: in one, the uptake was confirmed by MRI, and in the other, no anatomical localisation was found. In seven patients, no uptake was observed on both the scans.
Conclusion
124
I-PET proved to be a superior diagnostic tool as compared to low-dose diagnostic
131
I scans and adequately predicted findings on subsequent high-dose post-treatment
131
I scans.</description><subject>Adult</subject><subject>Aged</subject><subject>Aged, 80 and over</subject><subject>Cardiology</subject><subject>Comparative studies</subject><subject>Female</subject><subject>Humans</subject><subject>Imaging</subject><subject>Iodine Radioisotopes</subject><subject>Male</subject><subject>Medicine</subject><subject>Medicine & Public Health</subject><subject>Middle Aged</subject><subject>Nuclear Medicine</subject><subject>Oncology</subject><subject>Original</subject><subject>Original Article</subject><subject>Orthopedics</subject><subject>Positron-Emission Tomography - methods</subject><subject>Radiology</subject><subject>Radiopharmaceuticals</subject><subject>Reproducibility of Results</subject><subject>Sensitivity and Specificity</subject><subject>Thyroid cancer</subject><subject>Thyroid diseases</subject><subject>Thyroid Neoplasms - diagnostic imaging</subject><subject>Tomography</subject><issn>1619-7070</issn><issn>1619-7089</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2008</creationdate><recordtype>article</recordtype><sourceid>C6C</sourceid><sourceid>EIF</sourceid><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>AZQEC</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><sourceid>DWQXO</sourceid><sourceid>GNUQQ</sourceid><recordid>eNp1kU9rGzEQxUVpadK0H6CXInrobduRVn8vhRKSNBBIDs5ZyNpZW2G9cqXdhHz7ytgkbSAnPTG_eTPDI-Qzg-8MQP8oAFzapsoGlIJGvSHHTDHbaDD27ZPWcEQ-lHIHwAw39j05YoZpyZg8JteLNdIu-tWYyhQDvffDjDT1lHFx2dycLWgc6dZPEcep0Ic4rSvd95jrP_oJOzqtH3OKHQ1-DJg_kne9Hwp-Orwn5Pb8bHH6u7m6vrg8_XXVhJZx1XihWyXBIxgWDNeIirPO-FYA00b4LtTDWr4UGKw0vRaoPFeW66UKiIK3J-Tn3nc7LzfYhbpO9oPb5rjx-dElH93_lTGu3SrdO86ri5XV4NvBIKc_M5bJbWIJOAx-xDQXp0GCVFJX8OsL8C7NeazHOc6EEspaUSG2h0JOpWTsnzZh4HZZuX1Wbid3WTlVe778e8JzxyGcCvA9UGppXGF-nvy6619v4J4d</recordid><startdate>200805</startdate><enddate>200805</enddate><creator>Phan, Ha T. T.</creator><creator>Jager, Pieter L.</creator><creator>Paans, Anne M. J.</creator><creator>Plukker, John T. M.</creator><creator>Sturkenboom, M. G. G.</creator><creator>Sluiter, W. J.</creator><creator>Wolffenbuttel, Bruce H. R.</creator><creator>Dierckx, Rudi A. J. O.</creator><creator>Links, Thera P.</creator><general>Springer Berlin Heidelberg</general><general>Springer Nature B.V</general><scope>C6C</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7RV</scope><scope>7TK</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8AO</scope><scope>8FE</scope><scope>8FG</scope><scope>8FH</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>ARAPS</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BENPR</scope><scope>BGLVJ</scope><scope>BHPHI</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>HCIFZ</scope><scope>K9.</scope><scope>KB0</scope><scope>LK8</scope><scope>M0S</scope><scope>M1P</scope><scope>M7P</scope><scope>NAPCQ</scope><scope>P5Z</scope><scope>P62</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>200805</creationdate><title>The diagnostic value of 124I-PET in patients with differentiated thyroid cancer</title><author>Phan, Ha T. T. ; Jager, Pieter L. ; Paans, Anne M. J. ; Plukker, John T. M. ; Sturkenboom, M. G. G. ; Sluiter, W. J. ; Wolffenbuttel, Bruce H. R. ; Dierckx, Rudi A. J. O. ; Links, Thera P.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c3126-a473650ae081c827ee621d8a3401784adc25932b4ec958f74e6a26927b6cee423</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2008</creationdate><topic>Adult</topic><topic>Aged</topic><topic>Aged, 80 and over</topic><topic>Cardiology</topic><topic>Comparative studies</topic><topic>Female</topic><topic>Humans</topic><topic>Imaging</topic><topic>Iodine Radioisotopes</topic><topic>Male</topic><topic>Medicine</topic><topic>Medicine & Public Health</topic><topic>Middle Aged</topic><topic>Nuclear Medicine</topic><topic>Oncology</topic><topic>Original</topic><topic>Original Article</topic><topic>Orthopedics</topic><topic>Positron-Emission Tomography - methods</topic><topic>Radiology</topic><topic>Radiopharmaceuticals</topic><topic>Reproducibility of Results</topic><topic>Sensitivity and Specificity</topic><topic>Thyroid cancer</topic><topic>Thyroid diseases</topic><topic>Thyroid Neoplasms - diagnostic imaging</topic><topic>Tomography</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Phan, Ha T. T.</creatorcontrib><creatorcontrib>Jager, Pieter L.</creatorcontrib><creatorcontrib>Paans, Anne M. J.</creatorcontrib><creatorcontrib>Plukker, John T. M.</creatorcontrib><creatorcontrib>Sturkenboom, M. G. G.</creatorcontrib><creatorcontrib>Sluiter, W. J.</creatorcontrib><creatorcontrib>Wolffenbuttel, Bruce H. R.</creatorcontrib><creatorcontrib>Dierckx, Rudi A. J. O.</creatorcontrib><creatorcontrib>Links, Thera P.</creatorcontrib><collection>Springer Nature OA Free Journals</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Nursing & Allied Health Database</collection><collection>Neurosciences Abstracts</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Technology Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>Advanced Technologies & Aerospace Collection</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>ProQuest Central</collection><collection>Technology Collection</collection><collection>Natural Science Collection</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>SciTech Premium Collection</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Nursing & Allied Health Database (Alumni Edition)</collection><collection>ProQuest Biological Science Collection</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Biological Science Database</collection><collection>Nursing & Allied Health Premium</collection><collection>Advanced Technologies & Aerospace Database</collection><collection>ProQuest Advanced Technologies & Aerospace Collection</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>European journal of nuclear medicine and molecular imaging</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Phan, Ha T. T.</au><au>Jager, Pieter L.</au><au>Paans, Anne M. J.</au><au>Plukker, John T. M.</au><au>Sturkenboom, M. G. G.</au><au>Sluiter, W. J.</au><au>Wolffenbuttel, Bruce H. R.</au><au>Dierckx, Rudi A. J. O.</au><au>Links, Thera P.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>The diagnostic value of 124I-PET in patients with differentiated thyroid cancer</atitle><jtitle>European journal of nuclear medicine and molecular imaging</jtitle><stitle>Eur J Nucl Med Mol Imaging</stitle><addtitle>Eur J Nucl Med Mol Imaging</addtitle><date>2008-05</date><risdate>2008</risdate><volume>35</volume><issue>5</issue><spage>958</spage><epage>965</epage><pages>958-965</pages><issn>1619-7070</issn><eissn>1619-7089</eissn><abstract>Background
The purpose of this prospective study was to evaluate the clinical diagnostic value of iodine-124 (
124
I)-positron emission tomography (PET) in patients with advanced differentiated thyroid carcinoma (DTC) and to compare the
124
I-PET imaging results with the
131
I whole-body scan (WBS).
Materials and methods
Twenty patients with histologically proven advanced DTC (including T4, extra-nodal tumour growth, or distant metastases) underwent diagnostic
131
I-WBS,
124
I-PET scan, and post-treatment
131
I-WBS 4 months after ablation. The findings on the
124
I-PET were compared with the findings on the diagnostic and post-therapeutic
131
I-WBS and were also correlated with radiologic and/or cytological investigations.
Results
124
I-PET vs diagnostic
131
I-WBS
. Eleven patients showed uptake on the
124
I-PET. Only 3 of these 11 patients also showed uptake on the diagnostic
131
I scan, but the uptake was more clearly visible and the abnormalities were more extensive on the
124
I-PET.
124
I-PET vs post-treatment
131
I-WBS
. Eleven patients showed uptake on the
124
I-PET, which was also visible on the post-treatment scan in nine patients; in the other two patients, no uptake was observed on the post-treatment scan and no anatomical localisation could be confirmed. Two patients showed only uptake on the post-treatment scan without uptake on the
124
I-PET: in one, the uptake was confirmed by MRI, and in the other, no anatomical localisation was found. In seven patients, no uptake was observed on both the scans.
Conclusion
124
I-PET proved to be a superior diagnostic tool as compared to low-dose diagnostic
131
I scans and adequately predicted findings on subsequent high-dose post-treatment
131
I scans.</abstract><cop>Berlin/Heidelberg</cop><pub>Springer Berlin Heidelberg</pub><pmid>18175115</pmid><doi>10.1007/s00259-007-0660-6</doi><tpages>8</tpages><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 1619-7070 |
| ispartof | European journal of nuclear medicine and molecular imaging, 2008-05, Vol.35 (5), p.958-965 |
| issn | 1619-7070 1619-7089 |
| language | eng |
| recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_2292795 |
| source | MEDLINE; SpringerLink Journals - AutoHoldings |
| subjects | Adult Aged Aged, 80 and over Cardiology Comparative studies Female Humans Imaging Iodine Radioisotopes Male Medicine Medicine & Public Health Middle Aged Nuclear Medicine Oncology Original Original Article Orthopedics Positron-Emission Tomography - methods Radiology Radiopharmaceuticals Reproducibility of Results Sensitivity and Specificity Thyroid cancer Thyroid diseases Thyroid Neoplasms - diagnostic imaging Tomography |
| title | The diagnostic value of 124I-PET in patients with differentiated thyroid cancer |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-06T10%3A18%3A54IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=The%20diagnostic%20value%20of%20124I-PET%20in%20patients%20with%20differentiated%20thyroid%20cancer&rft.jtitle=European%20journal%20of%20nuclear%20medicine%20and%20molecular%20imaging&rft.au=Phan,%20Ha%20T.%20T.&rft.date=2008-05&rft.volume=35&rft.issue=5&rft.spage=958&rft.epage=965&rft.pages=958-965&rft.issn=1619-7070&rft.eissn=1619-7089&rft_id=info:doi/10.1007/s00259-007-0660-6&rft_dat=%3Cproquest_pubme%3E1468404171%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=214646994&rft_id=info:pmid/18175115&rfr_iscdi=true |